Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2004

01-05-2004 | Article

Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus

Authors: B. Cauwelier, B. Gordts, P. Descheemaecker, H. Van Landuyt

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2004

Login to get access

Abstract

The emergence of heterogeneous populations of methicillin-resistant Staphylococcus aureus (MRSA) causes major problems in routine screening for MRSA. In heterogeneous MRSA populations, a proportion of bacterial cells show low-level resistance to oxacillin, with minimal inhibitory concentrations (MICs) of oxacillin ranging between 1 and 100 mg/l, while in homogeneous MRSA populations, the MIC of oxacillin for all cells is >100 mg/l. Routine oxacillin disk diffusion tests often fail to detect heterogeneous MRSA populations. In the present study, a recently proposed disk diffusion method that employs a cephamycin antibiotic (cefoxitin 30 μg; BD Sensi-disc, Becton Dickinson, Germany) was evaluated using 155 clinical isolates of S. aureus (73 mecA positive and 82 mecA negative). The results were compared with those of other MRSA screening techniques: a disk diffusion test with oxacillin 1 μg and cefoxitin 30 μg (BD Sensi-disc; Becton Dickinson), an MRSA latex agglutination test (Denka Seiken, Japan), and an oxacillin screen agar test (6 μg/ml; Becton Dickinson). Detection of the mecA gene by polymerase chain reaction was considered the gold standard. The performances of the different methods were determined and compared. The results showed that the cefoxitin disk diffusion test is preferable to the oxacillin disk diffusion method for routine screening to detect MRSA.
Literature
1.
go back to reference Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus. Minnesota and North Dakota, 1997–1999. J Am Med Assoc 282:1123–1125CrossRef Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus. Minnesota and North Dakota, 1997–1999. J Am Med Assoc 282:1123–1125CrossRef
2.
go back to reference Gorak EJ, Yamada SM, Brouwn JD (1999) Community-acquired methicillin-resistant Staphylococcus aureus in hospitalised adults and children without known risk factors. Clin Infect Dis 29:797–800PubMed Gorak EJ, Yamada SM, Brouwn JD (1999) Community-acquired methicillin-resistant Staphylococcus aureus in hospitalised adults and children without known risk factors. Clin Infect Dis 29:797–800PubMed
3.
go back to reference Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J Am Med Assoc 279:593–598 Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J Am Med Assoc 279:593–598
4.
go back to reference Berger B, Rohrer S (2002) Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178:165–171PubMed Berger B, Rohrer S (2002) Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178:165–171PubMed
5.
go back to reference Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 System, and the MRSA-Screen latex agglutination test. J Clin Microbiol 40:2766–2771PubMed Felten A, Grandry B, Lagrange PH, Casin I (2002) Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 System, and the MRSA-Screen latex agglutination test. J Clin Microbiol 40:2766–2771PubMed
6.
go back to reference Bignardi GE, Woodford N, Chapman A, Johnson AP, Speller DCE (1996) Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J Antimicrob Chemother 37:53–63 Bignardi GE, Woodford N, Chapman A, Johnson AP, Speller DCE (1996) Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J Antimicrob Chemother 37:53–63
7.
go back to reference National Committee for Laboratory Standards (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. NCCLS, Wayne National Committee for Laboratory Standards (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. NCCLS, Wayne
8.
go back to reference Cavassini M, Wenger A, Jaton K, Blanc DS, Bille J (1999) Evaluation of MRSA-Screen, a simple anti-PBP2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 37:1591–1594PubMed Cavassini M, Wenger A, Jaton K, Blanc DS, Bille J (1999) Evaluation of MRSA-Screen, a simple anti-PBP2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 37:1591–1594PubMed
9.
go back to reference Thornsberry C, Caruthers JQ, Baker CN (1973) Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother 4:263–269PubMed Thornsberry C, Caruthers JQ, Baker CN (1973) Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother 4:263–269PubMed
10.
go back to reference Marriott DJE, Karagiannis T, Harkness JH, Kearney P (1999) Further evaluation of the MRSA-Screen kit for rapid detection of methicillin resistance. J Clin Microbiol 38:2170–2173 Marriott DJE, Karagiannis T, Harkness JH, Kearney P (1999) Further evaluation of the MRSA-Screen kit for rapid detection of methicillin resistance. J Clin Microbiol 38:2170–2173
Metadata
Title
Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus
Authors
B. Cauwelier
B. Gordts
P. Descheemaecker
H. Van Landuyt
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1130-8

Other articles of this Issue 5/2004

European Journal of Clinical Microbiology & Infectious Diseases 5/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.